NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 874 filers reported holding NOVARTIS A G in Q3 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $653,000 | -81.1% | 6,896 | -82.8% | 0.01% | -78.3% |
| Q3 2018 | $3,446,000 | -60.1% | 40,000 | -65.0% | 0.02% | -52.1% |
| Q2 2018 | $8,635,000 | +232.9% | 114,309 | +256.3% | 0.05% | +242.9% |
| Q1 2018 | $2,594,000 | +290.7% | 32,080 | +305.8% | 0.01% | +366.7% |
| Q4 2017 | $664,000 | -76.3% | 7,905 | -76.5% | 0.00% | -84.2% |
| Q2 2017 | $2,804,000 | +26.0% | 33,588 | +12.1% | 0.02% | +11.8% |
| Q1 2017 | $2,226,000 | +364.7% | 29,975 | +393.9% | 0.02% | +750.0% |
| Q3 2016 | $479,000 | +116.7% | 6,069 | +99.0% | 0.00% | +100.0% |
| Q1 2016 | $221,000 | +76.8% | 3,050 | +140.3% | 0.00% | 0.0% |
| Q2 2015 | $125,000 | -91.7% | 1,269 | -91.7% | 0.00% | -87.5% |
| Q1 2015 | $1,514,000 | -34.7% | 15,352 | -37.6% | 0.01% | -46.7% |
| Q3 2014 | $2,318,000 | -43.7% | 24,620 | -49.1% | 0.02% | -62.5% |
| Q1 2014 | $4,116,000 | +80.2% | 48,413 | +70.3% | 0.04% | +185.7% |
| Q4 2013 | $2,284,000 | – | 28,420 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |